Research theme for competitive and other funds (2)：
2018 - 2024 子どもの感情障害に対する認知行動療法の統一プロトコルの有効性
2011 - 2015 Biological basis and possible tailor-made therapy of developmental disabilities with problematic social behavior
Papers (143)：
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Jun ichi Iga, Kazuyoshi Ogasawara, et al. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project. Psychiatry Research Communications. 2024. 4. 1
Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, et al. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. Neuropsychopharmacology reports. 2023
Yoshinori Sasaki, Yuki Hakosima, Kumi Inazaki, Yuki Mizumoto, Takayuki Okada, Katsunaka Mikami, Noa Tsujii, Masahide Usami. Clinical characteristics of child and adolescent psychiatric outpatients engaging in fireplay or arson: a case-control study. Child and adolescent psychiatry and mental health. 2023. 17. 1. 119-119
Naomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Yoshikazu Takaesu, Hitoshi Iida, Hiroyuki Muraoka, Fumitoshi Kodaka, et al. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study. Psychiatry and clinical neurosciences. 2023
Hitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, Naomi Hasegawa, Shusuke Numata, Kazuyoshi Ogasawara, Kenichiro Miura, Junya Matsumoto, Hikaru Hori, Jun-Ichi Iga, et al. Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project. Neuropsychopharmacology reports. 2023. 43. 1. 23-32
